Literature DB >> 8155119

Cancer of the ovary.

S A Cannistra1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8155119     DOI： 10.1056/NEJM199311183292108

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  68 in total

1.  AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

Authors:  Melissa K Brunckhorst; Dimitry Lerner; Shaomeng Wang; Qin Yu
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Surgical staging of cancer: impact on prognosis and potential for bias in clinical trials.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

Review 4.  Extracranial malignant germ cell tumors.

Authors:  Yogesh Kumar Sarin; Sushmita Nitin Bhatnagar
Journal:  Indian J Pediatr       Date:  2012-06-16       Impact factor: 1.967

Review 5.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

6.  Expression of EMSY gene in sporadic ovarian cancer.

Authors:  Julide Altinisik; Ates Karateke; Hakan Coksuer; Turgut Ulutin; Nur Buyru
Journal:  Mol Biol Rep       Date:  2010-03-28       Impact factor: 2.316

7.  BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.

Authors:  T Strobel; L Swanson; S Korsmeyer; S A Cannistra
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.

Authors:  Limin Hu; Judith Hofmann; Charles Zaloudek; Napoleone Ferrara; Thomas Hamilton; Robert B Jaffe
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 9.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

10.  Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats.

Authors:  Allison C Sharrow; Brigitte M Ronnett; Christopher J Thoburn; James P Barber; Robert L Giuntoli; Deborah K Armstrong; Richard J Jones; Allan D Hess
Journal:  J Ovarian Res       Date:  2010-03-31       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.